Deutsche Bank’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-649
Closed -$16.2K 3864
2023
Q2
$16.2K Sell
649
-771
-54% -$22.6K ﹤0.01% 3601
2023
Q1
$51.6K Sell
1,420
-354
-20% -$21.7K ﹤0.01% 3539
2022
Q4
$107K Sell
1,774
-436
-20% -$29.2K ﹤0.01% 3303
2022
Q3
$166K Buy
2,210
+1,473
+200% +$154K ﹤0.01% 3054
2022
Q2
$84K Sell
737
-146
-17% -$17.1K ﹤0.01% 3597
2022
Q1
$167K Buy
883
+643
+268% +$149K ﹤0.01% 3359
2021
Q4
$83K Buy
240
+13
+6% +$5.04K ﹤0.01% 3781
2021
Q3
$76K Buy
+227
New +$116K ﹤0.01% 4006

Other funds holding OMIC

Deutsche Bank's OMIC Position: Q3 2023 in Review

Deutsche Bank sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q3 2023, closing a stake of 649 shares — an estimated $16.2K sold.

Deutsche Bank first reported a position in OMIC in Q3 2021 and held it in 8 quarters. The position peaked at $167K in Q1 2022. 48 funds tracked by Wall St. Rank hold OMIC as of Q3 2023.

  • Deutsche Bank reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Deutsche Bank sold 649 Singular Genomics Systems, Inc. Common Stock shares in Q3 2023, an estimated $16.2K.
  • Deutsche Bank first reported a position in Singular Genomics Systems, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
  • Deutsche Bank's Singular Genomics Systems, Inc. Common Stock position peaked at $167K in Q1 2022.
  • 48 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q3 2023.

Based on Deutsche Bank's 13F filing for Q3 2023, filed 9 Nov 2023.